dc.contributor.author | Rizzo, A | |
dc.contributor.author | Racca, M | |
dc.contributor.author | Dall'Armellina, S | |
dc.contributor.author | Rescigno, P | |
dc.contributor.author | Banna, GL | |
dc.contributor.author | Albano, D | |
dc.contributor.author | Dondi, F | |
dc.contributor.author | Bertagna, F | |
dc.contributor.author | Annunziata, S | |
dc.contributor.author | Treglia, G | |
dc.coverage.spatial | Switzerland | |
dc.date.accessioned | 2023-04-03T11:07:16Z | |
dc.date.available | 2023-04-03T11:07:16Z | |
dc.date.issued | 2023-01-05 | |
dc.identifier | ARTN 355 | |
dc.identifier | cancers15020355 | |
dc.identifier.citation | Cancers, 2023, 15 (2), pp. 355 - | |
dc.identifier.issn | 2072-6694 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5734 | |
dc.identifier.eissn | 2072-6694 | |
dc.identifier.eissn | 2072-6694 | |
dc.identifier.doi | 10.3390/cancers15020355 | |
dc.description.abstract | BACKGROUND: Recent articles proposed the employment of positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals in clear cell renal cell carcinoma (ccRCC). METHODS: The authors performed a comprehensive literature search of studies on the performance of PET/CT with PSMA-targeting radiopharmaceuticals in ccRCC. Original articles concerning this imaging examination were included in newly diagnosed ccRCC patients and ccRCC patients with disease recurrence. RESULTS: A total of sixteen papers concerning the diagnostic performance of PSMA-targeted PET/CT in ccRCC (331 patients) were included in this systematic review. The included articles demonstrated an excellent detection rate of PSMA-targeting PET/CT in ccRCC. CONCLUSIONS: PSMA-targeted PET/CT seems promising in detecting ccRCC lesions as well as in discriminating the presence of aggressive phenotypes. Prospective multicentric studies are warranted to strengthen the role of PSMA-targeting PET/CT in ccRCC. | |
dc.format | Electronic | |
dc.format.extent | 355 - | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | MDPI | |
dc.relation.ispartof | Cancers | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | PET | |
dc.subject | PSMA | |
dc.subject | clear cell renal cell carcinoma | |
dc.subject | imaging | |
dc.subject | kidney | |
dc.subject | nuclear medicine | |
dc.subject | oncology | |
dc.title | The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2023-01-03 | |
dc.date.updated | 2023-04-03T11:04:35Z | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.3390/cancers15020355 | |
rioxxterms.licenseref.startdate | 2023-01-05 | |
rioxxterms.type | Journal Article/Review | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/36672305 | |
pubs.issue | 2 | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.publication-status | Published online | |
pubs.publisher-url | http://dx.doi.org/10.3390/cancers15020355 | |
pubs.volume | 15 | |
icr.researchteam | PrCa Targeted Therapy | |
dc.contributor.icrauthor | Rescigno, Pasquale | |
icr.provenance | Deposited by Mr Arek Surman on 2023-04-03. Deposit type is initial. No. of files: 1. Files: The Emerging Role of PETCT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer An Updated Systematic Review.pdf | |